Spots Global Cancer Trial Database for A Study of SHR-1501 in Patients With Advanced Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of SHR-1501 in Patients With Advanced Tumors
Official Title: A Phase I Study on Tolerance, Safety and Pharmacokinetics of SHR-1501 in Patients With Advanced Malignancies.
Study ID: NCT04025957
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the safety and tolerability of SHR-1501 in patients with advanced malignancies .
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Cancer hospital, Chinese academy of medical sciences, Beijing, , China
Contact Details
Name: Jing Huang, MD
Affiliation: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
